Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Lyra Therapeutics Q2 EPS $(0.43) Up From $(0.85) YoY

Lyra Therapeutics (NASDAQ:LYRA) reported quarterly losses of $(0.43) per share. This is a 49.41 percent increase over losses of $(0.85) per share from the same period last year.
byBenzinga Newsdesk
August 9, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

Lyra Therapeutics (NASDAQ:LYRA) reported quarterly losses of $(0.43) per share. This is a 49.41 percent increase over losses of $(0.85) per share from the same period last year.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Edwards Lifesciences Presents 5-Year Follow Up Data From PARTNER Trials Showing Clinical Outcomes For Female And Small Annulus Patients With Transcatheter Aortic Valve Replacement At The New York Valves 2024: The Structural Heart Summit

By Benzinga Newsdesk
June 5, 11:48 AM
Edwards Lifesciences (NYSE:EW) today announced the results from an analysis of data from the PARTNER Trials examining outcomes of transcatheter aortic valve replacement (TAVR) patients with a small annulus. Through

EW